Literature DB >> 16000682

Selective serotonin reuptake inhibitors and patients with carcinoid tumor.

Mark D Williams1, Tamara J Dolenc.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16000682     DOI： 10.1176/appi.psy.46.4.370

Source DB:  PubMed          Journal:  Psychosomatics        ISSN： 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  5 in total

1.  Antidepressants appear safe in patients with carcinoid tumor: Results of a retrospective review.

Authors:  Elie Isenberg-Grzeda; Meredith MacGregor; Afton Bergel; Stacy Eagle; Fernando Espi Forcen; Reema Mehta; Konstantina Matsoukas; Jonathan Wills; Diane Reidy-Lagunes; Yesne Alici
Journal:  Eur J Surg Oncol       Date:  2018-03-21       Impact factor: 4.424

2.  Neuroendocrine carcinoid cancer associated with psychosis.

Authors:  Izchak Kohen; Sascha Arbouet
Journal:  Psychiatry (Edgmont)       Date:  2008-06

3.  Must antidepressants be avoided in patients with neuroendocrine tumors? Results of a systematic review.

Authors:  Elie Isenberg-Grzeda; Meredith MacGregor; Konstantina Matsoukas; Ngai Chow; Diane Reidy-Lagunes; Yesne Alici
Journal:  Palliat Support Care       Date:  2020-10

4.  Use of antidepressant serotoninergic medications and cardiac valvulopathy: a nested case-control study in the health improvement network (THIN) database.

Authors:  Francesco Lapi; Federica Nicotra; Lorenza Scotti; Alfredo Vannacci; Mary Thompson; Francesco Pieri; Niccolò Mugelli; Antonella Zambon; Giovanni Corrao; Alessandro Mugelli; Annalisa Rubino
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

5.  Right and Left-Sided Carcinoid Heart Disease in the Setting of Selective Serotonin Reuptake Inhibitor Use.

Authors:  Jennifer Bell; Maad Alhudairy; Vera Kazakova; Michael Johnstone; Lana Tsao
Journal:  JACC Case Rep       Date:  2020-10-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.